Company Mega Genomics Limited

Equities

6667

KYG5960G1047

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Chiffre d''affaires - Rate of surprise

Sector Medical & Diagnostic Laboratories

Market Closed - Hong Kong S.E. Other stock markets 09:09:00 03/05/2024 BST			5-day change	1st Jan Change
10.68 ^HKD	+7.01%		+17.36%	+3.69%

03-26	Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-12	Mega Genomics Stockholders to Vote March 1 on Continuing Transactions	MT

Mega Genomics Ltd is a China-based investment holding company principally engaged in genetic testing business. The Company operates its businesses through three segments. The Consumer Genetic Testing Services segment provides testing for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing. The Cancer Screening Services segment provides Septin9 colorectal cancer screening test, Syndecan-2 (SDC2) colorectal cancer screening test and ring finger protein 180 (RNF180)/Septin9 gastric cancer screening test. The Other Services segment provides genetic research and analysis services to third party research institutions.

Number of employees: 229

HKD in Million	2022	Weight	2023	Weight	Delta
Consumer Genetic Testing 71.6 %	94	55.3 %	120	71.6 %	+27.84%
Cancer Screening 28.4 %	76	44.7 %	47	28.4 %	-37.42%

HKD in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	169	100.0 %	167	100.0 %	-1.34%

Managers	Title	Age	Since
Jing Jiang CEO	Chief Executive Officer	44	-
Xiang Yi CTO	Chief Tech/Sci/R&D Officer	44	-
Xia An COO	Chief Operating Officer	41	-
Cong Li CTO	Chief Tech/Sci/R&D Officer	40	-
Xiani Gong PRN	Corporate Officer/Principal	38	-
Wai Kam Ng SEC	Corporate Secretary	49	25/07/21

Members of the board	Title	Age	Since
Rong Yu FOU	Founder	52	21/04/21
Mei Ling Guo BRD	Director/Board Member	54	05/08/21
Lin Lin CHM	Chairman	48	21/04/21
Jing Jiang CEO	Chief Executive Officer	44	-
Dan Xie BRD	Director/Board Member	43	05/08/21
Qing Feng Jia BRD	Director/Board Member	46	05/08/21
Ying Zhang BRD	Director/Board Member	45	05/08/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	236,764,800	122,782,422 ( 51.86 %)	0	51.86 %

Name	Equities	%	Valuation
Mei Ling Guo 9.932 %	23,515,000	9.932 %	30 M $
Lin Lin 6.133 %	14,520,644	6.133 %	19 M $
Main Sunflower Technology Ltd. 1.463 %	3,463,131	1.463 %	4 M $
Jing Jiang 0.2112 %	500,000	0.2112 %	640 135 $
Yu Feng Huang 0.000000 %	0	0.000000 %	- $

Mega Genomics Ltd.

401 Health Work North Garden Road

100191, Beijing

http://www.megagenomics.cn

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
MEGA GENOMICS LIMITED	+3.69%	324M
SONIC HEALTHCARE LIMITED	-18.58%	8.3B
SYNLAB AG	-8.58%	2.47B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-38.71%	2.46B
DR. LAL PATHLABS LIMITED	-10.06%	2.31B
NEOGENOMICS, INC.	-5.44%	1.95B
FLEURY S.A.	-17.79%	1.59B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.78%	1.21B
METROPOLIS HEALTHCARE LIMITED	+6.69%	1.1B
ADICON HOLDINGS LIMITED	-23.31%	931M

Medical & Diagnostic Laboratories